Actelion Opsumit macitentan Total Orphan Drugs

In by CameronLeave a Comment

Actelion Ltd today announced the approval of Opsumit (macitentan) 10 mg for the treatment of pulmonary arterial hypertension (PAH) by the Therapeutic Goods Administration (TGA) of Australia.

Leave a Comment